Aspirin, NSAID Risks Outweigh Colon Cancer Benefits – AHRQ Task Force
This article was originally published in The Tan Sheet
Executive Summary
A panel of prevention and primary care experts sponsored by the Agency for Healthcare Research and Quality is recommending against the use of aspirin and non-steroidal anti-inflammatory drugs for primary prevention of colorectal cancer